Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Aggressive B-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
B-Cell Malignant Neoplasm
B-Cell Non-Hodgkin Lymphoma
Aggressive B-Cell Non-Hodgkin Lymphoma

Hematologic Malignancy

Aggressive B-Cell Non-Hodgkin Lymphoma

CI-CAN-00001751Explore in graph →

Hematologic115 active trials4 evidence items

NCIt: C178541

Overview
Statistics
Survival
Genomics7
Variants & evidence4
Drugs2
Trials400
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

400 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 115
Recruiting: 56
Ph III recruiting: 1
Growth YoY: —
Industry share: 17%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (72)

StatusAll Active (any)Completed 184 Recruiting 62 Terminated 58 Active Not Recruiting 48 Unknown 19 Not Yet Recruiting 13 Withdrawn 12 Suspended 3 Approved For Marketing 1

PhaseAll Early Phase 1 8 N/A 29 Phase 1 186 Phase 2 201 Phase 3 15 Phase 4 3

No study matches these filters